Popular on TelAve
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- The ITeam Ranked on Channel Partners 2025 MSP 501—Tech Industry's Most Prestigious List of Managed Service Providers Worldwide
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Keepy Uppy™ by Ollyball Wins Prestigious 2025 Influencer Award from Clamour & The Toy Association; Announces Fall 2025 Launch at Target Stores
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research
- TCAA Welcomes Adolfo Gomez Sanchez to Its Family of Talented Speakers
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence
- Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
- Honoring Black History, Culture, and Community in Fall River
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
Similar on TelAve
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Mensa Foundation Prize Awarded to Neuroscientist-Pianist
- Global Court Momentum Builds Against Forced Psychiatry; CCHR Urges U.S. Reform
- Urgent Reform Demanded to Stop Child Abuse in Youth Behavioral Facilities
- CCHR Warns: Millions of Children Exposed to Risky Psychiatric Drugs
- Group Seeks End to Mandated Community Psychiatric Programs, Citing Global Alarm
- Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
AI-powered Virtual Staining of Biopsies for Transplant Diagnostics
TelAve News/10868193
LOS ANGELES - TelAve -- Organ transplantation offers life-saving treatment for patients with end-stage organ failure, restoring function and vastly improving quality of life for thousands each year. Yet, transplant rejection remains a leading cause of morbidity in lung and heart recipients, with up to 29% of lung and 25% of heart transplant patients experiencing acute rejection within the first year. The clinical imperative to detect rejection as early and accurately as possible places a heavy demand on pathology workflows, which hinge on laborious histochemical staining of minute biopsy fragments. The conventional chemical staining process of multiple stains not only adds days to diagnostic turnaround—delaying critical treatment decisions—but also incurs high reagent and labor costs. Moreover, chemical staining is susceptible to tissue handling artifacts, uneven dye uptake, and batch-to-batch color variability, all of which can obscure subtle tissue changes associated with transplant rejection and complicate pathologist interpretation.
More on TelAve News
To address these problems, a research team led by Professor Aydogan Ozcan at the University of California, Los Angeles (UCLA), in collaboration with histopathologists from the University of Southern California (USC) and University of California, Davis, recently published an article in BME Frontiers (AAAS), demonstrating a panel of deep neural networks that virtually generate Hematoxylin & Eosin (H&E), Masson's Trichrome (MT), and Verhoeff-Van Gieson (EVG) stains for label-free lung tissue, as well as H&E and MT stains for label-free heart tissue. By feeding autofluorescence microscopic images of unstained biopsy sections through these AI models, researchers digitally produce high-fidelity virtual slides, faithfully replicating multiple chemical stains and highlighting transplant rejection features without using any reagents.
In a blinded study involving four board-certified pathologists, the virtual stains achieved concordance rates of 82.4% for lung biopsies and 91.7% for heart biopsies in diagnosing transplant rejection, compared with conventional chemical staining methods. Quantitative assessment of the staining quality of nuclear, cytoplasmic, and extracellular features demonstrated non-inferiority of the virtual slides—and in some cases, virtual H&E outperformed standard stains, especially when histochemical artifacts were present. Beyond staining speed and accuracy, the virtual tissue staining approach also ensures consistent color uniformity across all slides, reducing inter-batch variability—a key advantage for downstream AI-based automatic detection and diagnostic workflows. Moreover, by virtually generating multiple stains from a single unstained tissue section, the framework eradicates the structural mismatches inherent to staining adjacent sections and streamlines pathologist review by obviating the need to align serial images manually.
More on TelAve News
Overall, this work lays the foundation for scalable, cost-effective digital pathology workflows in transplant medicine and paves the way for downstream AI-driven diagnostic tools that depend on standardized image inputs.
Article: https://spj.science.org/doi/10.34133/bmef.0151
More on TelAve News
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
To address these problems, a research team led by Professor Aydogan Ozcan at the University of California, Los Angeles (UCLA), in collaboration with histopathologists from the University of Southern California (USC) and University of California, Davis, recently published an article in BME Frontiers (AAAS), demonstrating a panel of deep neural networks that virtually generate Hematoxylin & Eosin (H&E), Masson's Trichrome (MT), and Verhoeff-Van Gieson (EVG) stains for label-free lung tissue, as well as H&E and MT stains for label-free heart tissue. By feeding autofluorescence microscopic images of unstained biopsy sections through these AI models, researchers digitally produce high-fidelity virtual slides, faithfully replicating multiple chemical stains and highlighting transplant rejection features without using any reagents.
In a blinded study involving four board-certified pathologists, the virtual stains achieved concordance rates of 82.4% for lung biopsies and 91.7% for heart biopsies in diagnosing transplant rejection, compared with conventional chemical staining methods. Quantitative assessment of the staining quality of nuclear, cytoplasmic, and extracellular features demonstrated non-inferiority of the virtual slides—and in some cases, virtual H&E outperformed standard stains, especially when histochemical artifacts were present. Beyond staining speed and accuracy, the virtual tissue staining approach also ensures consistent color uniformity across all slides, reducing inter-batch variability—a key advantage for downstream AI-based automatic detection and diagnostic workflows. Moreover, by virtually generating multiple stains from a single unstained tissue section, the framework eradicates the structural mismatches inherent to staining adjacent sections and streamlines pathologist review by obviating the need to align serial images manually.
More on TelAve News
- Colbert Packaging Announces WBENC Recognition
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
Overall, this work lays the foundation for scalable, cost-effective digital pathology workflows in transplant medicine and paves the way for downstream AI-driven diagnostic tools that depend on standardized image inputs.
Article: https://spj.science.org/doi/10.34133/bmef.0151
Source: ucla ita
0 Comments
Latest on TelAve News
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
- Vertical Consultants Launches Interactive Lease Grader Tool for Cell Tower Property Owners
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild